カテゴリー： Market Monitor Global, 世界, 医療/バイオ

腎臓（腎）線維症の世界市場見通し2023年-2029年

◆英語タイトル：Kidney (Renal) Fibrosis Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8532 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：74 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Kidney (Renal) Fibrosis Market 調査レポートは次の情報を含め、グローバルにおけるの腎臓（腎）線維症市場規模と予測を収録しています。・世界の腎臓（腎）線維症市場：売上、2018年-2023年、2024年-2029年
・世界の腎臓（腎）線維症市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腎臓（腎）線維症市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アンジオテンシン変換酵素（ACE）阻害剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

腎臓（腎）線維症のグローバル主要企業は、Merck、 Pfizer、 Roche、 InterMune、 Galectin Therapeutics、 La Jolla Pharmaceutical Company、 ProMetic Life-Sciences Inc.、 BioLine Rx Ltd、 Genzyme Corporationなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、腎臓（腎）線維症のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の腎臓（腎）線維症市場：タイプ別、2018年-2023年、2024年-2029年
世界の腎臓（腎）線維症市場：タイプ別市場シェア、2022年
・アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体拮抗薬（ARB）、バソペプチダーゼ阻害剤

世界の腎臓（腎）線維症市場：用途別、2018年-2023年、2024年-2029年
世界の腎臓（腎）線維症市場：用途別市場シェア、2022年
・研究センター、病院、診療所

世界の腎臓（腎）線維症市場：地域・国別、2018年-2023年、2024年-2029年
世界の腎臓（腎）線維症市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における腎臓（腎）線維症のグローバル売上、2018年-2023年
・主要企業における腎臓（腎）線維症のグローバル売上シェア、2022年
・主要企業における腎臓（腎）線維症のグローバル販売量、2018年-2023年
・主要企業における腎臓（腎）線維症のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck、 Pfizer、 Roche、 InterMune、 Galectin Therapeutics、 La Jolla Pharmaceutical Company、 ProMetic Life-Sciences Inc.、 BioLine Rx Ltd、 Genzyme Corporation

*************************************************************

・調査・分析レポートの概要
腎臓（腎）線維症市場の定義
市場セグメント
世界の腎臓（腎）線維症市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腎臓（腎）線維症市場規模
世界の腎臓（腎）線維症市場規模：2022年 VS 2029年
世界の腎臓（腎）線維症市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腎臓（腎）線維症の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腎臓（腎）線維症製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体拮抗薬（ARB）、バソペプチダーゼ阻害剤
腎臓（腎）線維症のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：研究センター、病院、診療所
腎臓（腎）線維症の用途別グローバル売上・予測

・地域別市場分析
地域別腎臓（腎）線維症市場規模 2022年と2029年
地域別腎臓（腎）線維症売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Pfizer、 Roche、 InterMune、 Galectin Therapeutics、 La Jolla Pharmaceutical Company、 ProMetic Life-Sciences Inc.、 BioLine Rx Ltd、 Genzyme Corporation
...

Kidney fibrosis is characterized by excessive production and deposition of extracellular matrix (ECM) proteins mainly in the kidney interstitium and results in structural damage, impairment of renal function, and eventually end-stage renal disease (ESRD).
This report aims to provide a comprehensive presentation of the global market for Kidney (Renal) Fibrosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney (Renal) Fibrosis. This report contains market size and forecasts of Kidney (Renal) Fibrosis in global, including the following market information:
Global Kidney (Renal) Fibrosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Kidney (Renal) Fibrosis Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Kidney (Renal) Fibrosis companies in 2022 (%)
The global Kidney (Renal) Fibrosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Angiotensin Converting enzyme (ACE) Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Kidney (Renal) Fibrosis include Merck, Pfizer, Roche, InterMune, Galectin Therapeutics, La Jolla Pharmaceutical Company, ProMetic Life-Sciences Inc., BioLine Rx Ltd and Genzyme Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney (Renal) Fibrosis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney (Renal) Fibrosis Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Kidney (Renal) Fibrosis Market Segment Percentages, by Type, 2022 (%)
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Global Kidney (Renal) Fibrosis Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Kidney (Renal) Fibrosis Market Segment Percentages, by Application, 2022 (%)
Research Center
Hospital
Clinic
Global Kidney (Renal) Fibrosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Kidney (Renal) Fibrosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney (Renal) Fibrosis revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Kidney (Renal) Fibrosis revenues share in global market, 2022 (%)
Key companies Kidney (Renal) Fibrosis sales in global market, 2018-2023 (Estimated), (MT)
Key companies Kidney (Renal) Fibrosis sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc.
BioLine Rx Ltd
Genzyme Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Kidney (Renal) Fibrosis, market overview.
Chapter 2: Global Kidney (Renal) Fibrosis market size in revenue and volume.
Chapter 3: Detailed analysis of Kidney (Renal) Fibrosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney (Renal) Fibrosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Kidney (Renal) Fibrosis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Kidney (Renal) Fibrosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney (Renal) Fibrosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney (Renal) Fibrosis Overall Market Size
2.1 Global Kidney (Renal) Fibrosis Market Size: 2022 VS 2029
2.2 Global Kidney (Renal) Fibrosis Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Kidney (Renal) Fibrosis Sales: 2018-2029
3 Company Landscape
3.1 Top Kidney (Renal) Fibrosis Players in Global Market
3.2 Top Global Kidney (Renal) Fibrosis Companies Ranked by Revenue
3.3 Global Kidney (Renal) Fibrosis Revenue by Companies
3.4 Global Kidney (Renal) Fibrosis Sales by Companies
3.5 Global Kidney (Renal) Fibrosis Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Kidney (Renal) Fibrosis Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Kidney (Renal) Fibrosis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney (Renal) Fibrosis Players in Global Market
3.8.1 List of Global Tier 1 Kidney (Renal) Fibrosis Companies
3.8.2 List of Global Tier 2 and Tier 3 Kidney (Renal) Fibrosis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Kidney (Renal) Fibrosis Market Size Markets, 2022 & 2029
4.1.2 Angiotensin Converting enzyme (ACE) Inhibitors
4.1.3 Pirfenidone
4.1.4 Renin Inhibitors
4.1.5 Angiotensin II Receptor Blockers (ARBs)
4.1.6 Vasopeptidase Inhibitors
4.2 By Type – Global Kidney (Renal) Fibrosis Revenue & Forecasts
4.2.1 By Type – Global Kidney (Renal) Fibrosis Revenue, 2018-2023
4.2.2 By Type – Global Kidney (Renal) Fibrosis Revenue, 2024-2029
4.2.3 By Type – Global Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
4.3 By Type – Global Kidney (Renal) Fibrosis Sales & Forecasts
4.3.1 By Type – Global Kidney (Renal) Fibrosis Sales, 2018-2023
4.3.2 By Type – Global Kidney (Renal) Fibrosis Sales, 2024-2029
4.3.3 By Type – Global Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
4.4 By Type – Global Kidney (Renal) Fibrosis Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Kidney (Renal) Fibrosis Market Size, 2022 & 2029
5.1.2 Research Center
5.1.3 Hospital
5.1.4 Clinic
5.2 By Application – Global Kidney (Renal) Fibrosis Revenue & Forecasts
5.2.1 By Application – Global Kidney (Renal) Fibrosis Revenue, 2018-2023
5.2.2 By Application – Global Kidney (Renal) Fibrosis Revenue, 2024-2029
5.2.3 By Application – Global Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
5.3 By Application – Global Kidney (Renal) Fibrosis Sales & Forecasts
5.3.1 By Application – Global Kidney (Renal) Fibrosis Sales, 2018-2023
5.3.2 By Application – Global Kidney (Renal) Fibrosis Sales, 2024-2029
5.3.3 By Application – Global Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
5.4 By Application – Global Kidney (Renal) Fibrosis Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Kidney (Renal) Fibrosis Market Size, 2022 & 2029
6.2 By Region – Global Kidney (Renal) Fibrosis Revenue & Forecasts
6.2.1 By Region – Global Kidney (Renal) Fibrosis Revenue, 2018-2023
6.2.2 By Region – Global Kidney (Renal) Fibrosis Revenue, 2024-2029
6.2.3 By Region – Global Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
6.3 By Region – Global Kidney (Renal) Fibrosis Sales & Forecasts
6.3.1 By Region – Global Kidney (Renal) Fibrosis Sales, 2018-2023
6.3.2 By Region – Global Kidney (Renal) Fibrosis Sales, 2024-2029
6.3.3 By Region – Global Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Kidney (Renal) Fibrosis Revenue, 2018-2029
6.4.2 By Country – North America Kidney (Renal) Fibrosis Sales, 2018-2029
6.4.3 US Kidney (Renal) Fibrosis Market Size, 2018-2029
6.4.4 Canada Kidney (Renal) Fibrosis Market Size, 2018-2029
6.4.5 Mexico Kidney (Renal) Fibrosis Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Kidney (Renal) Fibrosis Revenue, 2018-2029
6.5.2 By Country – Europe Kidney (Renal) Fibrosis Sales, 2018-2029
6.5.3 Germany Kidney (Renal) Fibrosis Market Size, 2018-2029
6.5.4 France Kidney (Renal) Fibrosis Market Size, 2018-2029
6.5.5 U.K. Kidney (Renal) Fibrosis Market Size, 2018-2029
6.5.6 Italy Kidney (Renal) Fibrosis Market Size, 2018-2029
6.5.7 Russia Kidney (Renal) Fibrosis Market Size, 2018-2029
6.5.8 Nordic Countries Kidney (Renal) Fibrosis Market Size, 2018-2029
6.5.9 Benelux Kidney (Renal) Fibrosis Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Kidney (Renal) Fibrosis Revenue, 2018-2029
6.6.2 By Region – Asia Kidney (Renal) Fibrosis Sales, 2018-2029
6.6.3 China Kidney (Renal) Fibrosis Market Size, 2018-2029
6.6.4 Japan Kidney (Renal) Fibrosis Market Size, 2018-2029
6.6.5 South Korea Kidney (Renal) Fibrosis Market Size, 2018-2029
6.6.6 Southeast Asia Kidney (Renal) Fibrosis Market Size, 2018-2029
6.6.7 India Kidney (Renal) Fibrosis Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Kidney (Renal) Fibrosis Revenue, 2018-2029
6.7.2 By Country – South America Kidney (Renal) Fibrosis Sales, 2018-2029
6.7.3 Brazil Kidney (Renal) Fibrosis Market Size, 2018-2029
6.7.4 Argentina Kidney (Renal) Fibrosis Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Kidney (Renal) Fibrosis Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Kidney (Renal) Fibrosis Sales, 2018-2029
6.8.3 Turkey Kidney (Renal) Fibrosis Market Size, 2018-2029
6.8.4 Israel Kidney (Renal) Fibrosis Market Size, 2018-2029
6.8.5 Saudi Arabia Kidney (Renal) Fibrosis Market Size, 2018-2029
6.8.6 UAE Kidney (Renal) Fibrosis Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Kidney (Renal) Fibrosis Major Product Offerings
7.1.4 Merck Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Kidney (Renal) Fibrosis Major Product Offerings
7.2.4 Pfizer Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Kidney (Renal) Fibrosis Major Product Offerings
7.3.4 Roche Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 InterMune
7.4.1 InterMune Company Summary
7.4.2 InterMune Business Overview
7.4.3 InterMune Kidney (Renal) Fibrosis Major Product Offerings
7.4.4 InterMune Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.4.5 InterMune Key News & Latest Developments
7.5 Galectin Therapeutics
7.5.1 Galectin Therapeutics Company Summary
7.5.2 Galectin Therapeutics Business Overview
7.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Major Product Offerings
7.5.4 Galectin Therapeutics Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.5.5 Galectin Therapeutics Key News & Latest Developments
7.6 La Jolla Pharmaceutical Company
7.6.1 La Jolla Pharmaceutical Company Company Summary
7.6.2 La Jolla Pharmaceutical Company Business Overview
7.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Major Product Offerings
7.6.4 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.6.5 La Jolla Pharmaceutical Company Key News & Latest Developments
7.7 ProMetic Life-Sciences Inc.
7.7.1 ProMetic Life-Sciences Inc. Company Summary
7.7.2 ProMetic Life-Sciences Inc. Business Overview
7.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Major Product Offerings
7.7.4 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.7.5 ProMetic Life-Sciences Inc. Key News & Latest Developments
7.8 BioLine Rx Ltd
7.8.1 BioLine Rx Ltd Company Summary
7.8.2 BioLine Rx Ltd Business Overview
7.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Major Product Offerings
7.8.4 BioLine Rx Ltd Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.8.5 BioLine Rx Ltd Key News & Latest Developments
7.9 Genzyme Corporation
7.9.1 Genzyme Corporation Company Summary
7.9.2 Genzyme Corporation Business Overview
7.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Major Product Offerings
7.9.4 Genzyme Corporation Kidney (Renal) Fibrosis Sales and Revenue in Global (2018-2023)
7.9.5 Genzyme Corporation Key News & Latest Developments
8 Global Kidney (Renal) Fibrosis Production Capacity, Analysis
8.1 Global Kidney (Renal) Fibrosis Production Capacity, 2018-2029
8.2 Kidney (Renal) Fibrosis Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney (Renal) Fibrosis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kidney (Renal) Fibrosis Supply Chain Analysis
10.1 Kidney (Renal) Fibrosis Industry Value Chain
10.2 Kidney (Renal) Fibrosis Upstream Market
10.3 Kidney (Renal) Fibrosis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kidney (Renal) Fibrosis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Kidney (Renal) Fibrosis in Global Market
Table 2. Top Kidney (Renal) Fibrosis Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Kidney (Renal) Fibrosis Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Kidney (Renal) Fibrosis Revenue Share by Companies, 2018-2023
Table 5. Global Kidney (Renal) Fibrosis Sales by Companies, (MT), 2018-2023
Table 6. Global Kidney (Renal) Fibrosis Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Kidney (Renal) Fibrosis Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Kidney (Renal) Fibrosis Product Type
Table 9. List of Global Tier 1 Kidney (Renal) Fibrosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney (Renal) Fibrosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Kidney (Renal) Fibrosis Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Kidney (Renal) Fibrosis Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Kidney (Renal) Fibrosis Sales (MT), 2018-2023
Table 15. By Type - Global Kidney (Renal) Fibrosis Sales (MT), 2024-2029
Table 16. By Application – Global Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Kidney (Renal) Fibrosis Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Kidney (Renal) Fibrosis Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Kidney (Renal) Fibrosis Sales (MT), 2018-2023
Table 20. By Application - Global Kidney (Renal) Fibrosis Sales (MT), 2024-2029
Table 21. By Region – Global Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Kidney (Renal) Fibrosis Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Kidney (Renal) Fibrosis Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Kidney (Renal) Fibrosis Sales (MT), 2018-2023
Table 25. By Region - Global Kidney (Renal) Fibrosis Sales (MT), 2024-2029
Table 26. By Country - North America Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Kidney (Renal) Fibrosis Sales, (MT), 2018-2023
Table 29. By Country - North America Kidney (Renal) Fibrosis Sales, (MT), 2024-2029
Table 30. By Country - Europe Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Kidney (Renal) Fibrosis Sales, (MT), 2018-2023
Table 33. By Country - Europe Kidney (Renal) Fibrosis Sales, (MT), 2024-2029
Table 34. By Region - Asia Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Kidney (Renal) Fibrosis Sales, (MT), 2018-2023
Table 37. By Region - Asia Kidney (Renal) Fibrosis Sales, (MT), 2024-2029
Table 38. By Country - South America Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Kidney (Renal) Fibrosis Sales, (MT), 2018-2023
Table 41. By Country - South America Kidney (Renal) Fibrosis Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Kidney (Renal) Fibrosis Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Kidney (Renal) Fibrosis Sales, (MT), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Kidney (Renal) Fibrosis Product Offerings
Table 48. Merck Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Kidney (Renal) Fibrosis Product Offerings
Table 52. Pfizer Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Kidney (Renal) Fibrosis Product Offerings
Table 56. Roche Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. InterMune Company Summary
Table 59. InterMune Kidney (Renal) Fibrosis Product Offerings
Table 60. InterMune Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 61. InterMune Key News & Latest Developments
Table 62. Galectin Therapeutics Company Summary
Table 63. Galectin Therapeutics Kidney (Renal) Fibrosis Product Offerings
Table 64. Galectin Therapeutics Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 65. Galectin Therapeutics Key News & Latest Developments
Table 66. La Jolla Pharmaceutical Company Company Summary
Table 67. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product Offerings
Table 68. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 69. La Jolla Pharmaceutical Company Key News & Latest Developments
Table 70. ProMetic Life-Sciences Inc. Company Summary
Table 71. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product Offerings
Table 72. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 73. ProMetic Life-Sciences Inc. Key News & Latest Developments
Table 74. BioLine Rx Ltd Company Summary
Table 75. BioLine Rx Ltd Kidney (Renal) Fibrosis Product Offerings
Table 76. BioLine Rx Ltd Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 77. BioLine Rx Ltd Key News & Latest Developments
Table 78. Genzyme Corporation Company Summary
Table 79. Genzyme Corporation Kidney (Renal) Fibrosis Product Offerings
Table 80. Genzyme Corporation Kidney (Renal) Fibrosis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 81. Genzyme Corporation Key News & Latest Developments
Table 82. Kidney (Renal) Fibrosis Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 83. Global Kidney (Renal) Fibrosis Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Kidney (Renal) Fibrosis Production by Region, 2018-2023 (MT)
Table 85. Global Kidney (Renal) Fibrosis Production by Region, 2024-2029 (MT)
Table 86. Kidney (Renal) Fibrosis Market Opportunities & Trends in Global Market
Table 87. Kidney (Renal) Fibrosis Market Drivers in Global Market
Table 88. Kidney (Renal) Fibrosis Market Restraints in Global Market
Table 89. Kidney (Renal) Fibrosis Raw Materials
Table 90. Kidney (Renal) Fibrosis Raw Materials Suppliers in Global Market
Table 91. Typical Kidney (Renal) Fibrosis Downstream
Table 92. Kidney (Renal) Fibrosis Downstream Clients in Global Market
Table 93. Kidney (Renal) Fibrosis Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Kidney (Renal) Fibrosis Segment by Type in 2022
Figure 2. Kidney (Renal) Fibrosis Segment by Application in 2022
Figure 3. Global Kidney (Renal) Fibrosis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Kidney (Renal) Fibrosis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Kidney (Renal) Fibrosis Revenue, 2018-2029 (US$, Mn)
Figure 7. Kidney (Renal) Fibrosis Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Kidney (Renal) Fibrosis Revenue in 2022
Figure 9. By Type - Global Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 11. By Type - Global Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 12. By Type - Global Kidney (Renal) Fibrosis Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 15. By Application - Global Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 16. By Application - Global Kidney (Renal) Fibrosis Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Kidney (Renal) Fibrosis Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 20. By Region - Global Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 21. By Country - North America Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 22. By Country - North America Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 23. US Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 28. Germany Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 29. France Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 37. China Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 41. India Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 43. By Country - South America Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 44. Brazil Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Kidney (Renal) Fibrosis Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Kidney (Renal) Fibrosis Sales Market Share, 2018-2029
Figure 48. Turkey Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Kidney (Renal) Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 52. Global Kidney (Renal) Fibrosis Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Kidney (Renal) Fibrosis by Region, 2022 VS 2029
Figure 54. Kidney (Renal) Fibrosis Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 腎臓（腎）線維症の世界市場見通し2023年-2029年(Kidney (Renal) Fibrosis Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

腎臓（腎）線維症の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp